NNNN supply chain intelligence for Anbio Biotechnology: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Anbio Biotechnology (NNNN) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| SUPPLIER | SUPPLIER | 90% | For the year ended December 31, 2023, three suppliers accounted for 100% of the total purchases. |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| CUSTOMER | CUSTOMER | 90% | As of December 31, 2023, the balance due from four customers accounted for approximately 30%, 35%, 0%, and 19% of the Company’s total accounts receivable, respectively. |
| ANBIO-BIOTECHNOLOGY-LIMITED | ANBIO-BIOTECHNOLOGY-LIMITED | 62% | ed (“Anbio BVI”) ceased operations and was sold thereafter. Anbio Biotechnology Limited (“Anbio Samoa”) became the primary operational entity of our Company. Factors Affecting Our Operating Results T… |
| ANBIO-BIOTECHNOLOGY-PTY-LTD | ANBIO-BIOTECHNOLOGY-PTY-LTD | 62% | Item 16K. Cybersecurity Risk Management and Strategy As a global diagnostic company offering in vitro diagnostics products, we recognize the importance of developing, implementing, and maintaining ap… |
| ANBIO-LOVIWELL-INC | ANBIO-LOVIWELL-INC | 62% | Item 16K. Cybersecurity Risk Management and Strategy As a global diagnostic company offering in vitro diagnostics products, we recognize the importance of developing, implementing, and maintaining ap… |
| BEIJING-BIOMEDICAL-TECHNOLOGY-LIMITED | BEIJING-BIOMEDICAL-TECHNOLOGY-LIMITED | 62% | o expand our marketing capabilities to increase our brand awareness and generate demand across our markets. Our global go-to-market strategy primarily follows business-to-business (“B2B”) approach th… |
| DELAWARE-PHARVAC-LIMITED-BRITISH-VIRGIN-ISLANDS- | DELAWARE-PHARVAC-LIMITED-BRITISH-VIRGIN-ISLANDS- | 62% | o expand our marketing capabilities to increase our brand awareness and generate demand across our markets. Our global go-to-market strategy primarily follows business-to-business (“B2B”) approach th… |
| HONG-KONG-SAR-ANBIO-BIOTECHNOLOGY-PTY-LTD | HONG-KONG-SAR-ANBIO-BIOTECHNOLOGY-PTY-LTD | 62% | o expand our marketing capabilities to increase our brand awareness and generate demand across our markets. Our global go-to-market strategy primarily follows business-to-business (“B2B”) approach th… |
| INCORPORATION-ANBIO-BIOTECHNOLOGY-LIMITED | INCORPORATION-ANBIO-BIOTECHNOLOGY-LIMITED | 62% | o expand our marketing capabilities to increase our brand awareness and generate demand across our markets. Our global go-to-market strategy primarily follows business-to-business (“B2B”) approach th… |
| MONSANTO-CHEMICAL-CO | MONSANTO-CHEMICAL-CO | 62% | countants (ACCA), Certified Internal Auditor (CIA), Certified Information Systems Auditor (CISA), and Certified Information Security Manager (CISM). Chris Tian has been our Chief Business Officer sin… |
| NEW-CENTURY-AAA-INC | NEW-CENTURY-AAA-INC | 62% | countants (ACCA), Certified Internal Auditor (CIA), Certified Information Systems Auditor (CISA), and Certified Information Security Manager (CISM). Chris Tian has been our Chief Business Officer sin… |
| PHARVAC-BVI-LOVIWELL-INC | PHARVAC-BVI-LOVIWELL-INC | 62% | Item 16K. Cybersecurity Risk Management and Strategy As a global diagnostic company offering in vitro diagnostics products, we recognize the importance of developing, implementing, and maintaining ap… |
| PHARVAC-LIMITED | PHARVAC-LIMITED | 62% | Item 16K. Cybersecurity Risk Management and Strategy As a global diagnostic company offering in vitro diagnostics products, we recognize the importance of developing, implementing, and maintaining ap… |
| PRC-LOVIWELL-INC-BRITISH-VIRGIN-ISLANDS-LOVIWELL | PRC-LOVIWELL-INC-BRITISH-VIRGIN-ISLANDS-LOVIWELL | 62% | o expand our marketing capabilities to increase our brand awareness and generate demand across our markets. Our global go-to-market strategy primarily follows business-to-business (“B2B”) approach th… |
| SAMOA-ANBIO-BIOTECHNOLOGY-LIMITED | SAMOA-ANBIO-BIOTECHNOLOGY-LIMITED | 62% | o expand our marketing capabilities to increase our brand awareness and generate demand across our markets. Our global go-to-market strategy primarily follows business-to-business (“B2B”) approach th… |
| U-S-PUBLIC-COMPANY | U-S-PUBLIC-COMPANY | 62% | ies or investigations and lawsuits against us, and perceptions of conflicts of interest, inappropriate business conduct by us or perceived wrongdoing by any key member of our management team, among o… |
| WARNER-LAMBERT-INC | WARNER-LAMBERT-INC | 62% | countants (ACCA), Certified Internal Auditor (CIA), Certified Information Systems Auditor (CISA), and Certified Information Security Manager (CISM). Chris Tian has been our Chief Business Officer sin… |
| XIAMEN-LIMITED-PRC-BEIJING-ANBIAO-BIOTECHNOLOGY- | XIAMEN-LIMITED-PRC-BEIJING-ANBIAO-BIOTECHNOLOGY- | 62% | o expand our marketing capabilities to increase our brand awareness and generate demand across our markets. Our global go-to-market strategy primarily follows business-to-business (“B2B”) approach th… |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| NNNN-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC | GEODE CAPITAL MANAGEMENT, LLC | 90% | 13F overlay lists GEODE CAPITAL MANAGEMENT, LLC as top holder; 8 tracked holders. |